2-chloro-4-cyclobutylpyrimidine

Catalog No.: 
ACXVEO351
CAS No.: 
1215072-90-4
Molecular Formula: 
C8H9ClN2
Molecular Weight: 
168.63
2-chloro-4-cyclobutylpyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$427.00InquiryInquiry
250mg98%$711.00InquiryInquiry
1g98%$1221.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-chloro-4-cyclobutylpyrimidine
IUPAC Name2-chloro-4-cyclobutylpyrimidine
MDL No.MFCD14707215
Molecular FormulaC8H9ClN2
Molecular Weight168.63
SMILESClC1=NC=CC(C2CCC2)=N1
InChI KeyQVNRRVVLYBTXPQ-UHFFFAOYSA-N
Synonym2-chloro-4-cyclobutylpyrimidine;Pyrimidine, 2-chloro-4-cyclobutyl-
CAS No.1215072-90-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXVEO351 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXVEO351 route product structure diagram
    ACXVEO3511215072-90-4
Inquiry

2. ACXVEO351 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACXVEO351 route product structure diagram
    ACXVEO3511215072-90-4
Inquiry

3. ACXVEO351 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXVEO351 route product structure diagram
    ACXVEO3511215072-90-4
Inquiry

Comments (0)